Skip to content
WGS·Nasdaq·US

GeneDx

GeneDx combines clinical expertise, advanced technology, and its proprietary GeneDx Infinity dataset to power its ExomeDx and GenomeDx tests, which enable clinicians to diagnose genetic diseases. It sells diagnostic tests and related data and interpretation services to healthcare providers, patients, third-party payors, business-to-business clients, and biopharma partners, and positions itself as a leader in the genomic diagnostics industry.

Source: SEC 10-K Feb 23, 2026

Thematic Position

WGS

Relationship Groups

Suppliers4
Partners4
Competitors2

Relationship details are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

export controlimport restrictionsanctionembargo
International expansion subject to export/import restrictions, sanctions and embargoes
SEC 10-KFeb 23, 2026

The full regulatory passage is part of the Pro plan.

3 more · Regulatory and geopolitical insights are part of the Pro plan.